Back
Catalyst Pharmaceuticals Vs. A-Mark Precious Metals Industry Stock Comparison
Buy
53
CPRX
Catalyst Pharmaceuticals
Last Price:
20.22
Seasonality Move:
-9.33%
Buy
67
AMRK
A-Mark Precious Metals
Last Price:
46.90
Seasonality Move:
-0.66%
Buy
53
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $20.22. The Score for CPRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
A-Mark Precious Metals (AMRK)
is a Buy
Is A-Mark Precious Metals a Buy, Sell or Hold?
- The current A-Mark Precious Metals [AMRK] share price is $46.92. The Score for AMRK is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- AMRK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $20.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
AMRK Stock Price Chart
What is A-Mark Precious Metals's stock price today?
-
The A-Mark Precious Metals share price today is $46.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AMRK is experiencing slight buying pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.41 | Buy |
| Relative Strength Index (14 RSI): | 60.16 | Buy |
| Chaikin Money Flow: | -187954 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.41 - 20.45) | Buy |
| Bollinger Bands (100): | (15.08 - 18.84) | Buy |
AMRK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.59 | Buy |
| Relative Strength Index (14 RSI): | 80.49 | Buy |
| Chaikin Money Flow: | 83563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.66 - 42.68) | Buy |
| Bollinger Bands (100): | (33.96 - 40.2) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.79 | Buy |
| 20-day SMA: | 20.09 | Buy |
| 50-day SMA: | 18.31 | Buy |
| 200-day SMA: | 16.03 | Buy |
| 8-day EMA: | 19.91 | Buy |
| 20-day EMA: | 19.68 | Buy |
| 50-day EMA: | 18.62 | Buy |
| 200-day EMA: | 16.38 | Buy |
AMRK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44 | Buy |
| 20-day SMA: | 39.75 | Buy |
| 50-day SMA: | 37.36 | Buy |
| 200-day SMA: | 33.27 | Buy |
| 8-day EMA: | 43.89 | Buy |
| 20-day EMA: | 40.88 | Buy |
| 50-day EMA: | 38.25 | Buy |
| 200-day EMA: | 34.87 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
A-Mark Precious Metals Earnings Growth & AMRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.06 per share, a decrease this year of $3.67 per share, and an increase next year of $0.36 per share.
Catalyst Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
A-Mark Precious Metals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||